Home / About Us / Facilities / Injectable Facility
Injectable Facility

Sanzyme earlier known as Uni -Sankyo, the first ever Indo -Japanese joint venture, was established in 1969. The Company, headquartered in Hyderabad, India, expanded its activities and evolved as the manufacturer of Fermentation & Biotechnology products in the Country.

It is the first company in India to manufacture Human Chorionic Gonadotropin, spores of Lactic Acid Bacillus and Saccharomyces boulardii. During these four decades we have progressed well in the field of biotechnology and evolved ourselves based on our activities in rd, manufacturing and marketing. On the occasion of the 42nd Anniversary we have embarked on a path to discover higher potential in the field of Biotechnology. Therefore, keeping in view the strategic expansion of divisions associated with biotechnology, we are pleased to inform you that we have changed the name of our company to Sanzyme - which appropriately represents the flavour of the company.

We, at Sanzyme, owe a great deal of our success to the enduring strength of Sankyo Company Ltd., Japan. Their constant guidance especially in the angle of quality assurance and GMP [Good Manufacturing Practices] made us a high profile manufacturing and marketing company in India. With the experience that we have gained in building up our image over the last 42 years, we manufacture quality ethical products complying with the standards of WHO [World Health Organization] for GMP.

The business verticals, of Sanzyme are segmented primarily into:

Physical features:

  • Hormones
    • Gonadotropin Injections - Chorionic gonadotropin (hCG), Urofollitropin (FSH) and Menotropins (HMG)]
    • Progestins – Natural Micronized Progesterone Injections and Capsules and Hydroxy-Progesterone
    • Caproate Others – Nutraceuticals for PCOS, Cycle Regulators and weight reducing agents
  • Male Sexual Health
    • Nutraceutical preparations for MSD and Testosterone Tablets and Injections
  • Probiotics
    • For GI disorders and other chronic disorders such as hyperlipidaemia
  • Nephrology
    • Immune suppressants, Erythropoietin, drugs for reduction of phosphates and antibiotics for use in nephrology

Sanzyme, with its well-established research and development wing approved by DSIR [Ministry of Science and Technology], has sophisticated facilities for Analytical, Biological and Microbiological tests and research. Focus on Clinical research has been an integral part of research.

It is a matter of pride and honour for Sanzyme that the Ministry of Science and Technology of Government of India, recognizes our rd centre. Sanzyme has been growing over the years and is exporting products to various countries in the European Union and South Asia.

Sanzyme has other SBU's [Strategic Business Units] located in Hyderabad, with business interests in Fermentation Technology, Aquaculture, Poultry, Bio-remediation and Veterinary products, in addition to Probiotics for human consumption.

  Copyright © 2014 Sanzyme. All rights reserved.